Durable Response to Nivolumab in a Patient With Hepatic Sarcomatoid Carcinoma: Evolutive Characterization of Genomic and Immunohistochemical PD-L1 Expression Findings
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.